Skip to main content
SpringerLink
Log in

Macrolide antibiotics as antiinflammatory agents: Roxithromycin in an unexpected role

  • Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The antiinflammatory activity of a new 14-membered macrolide antibiotic, roxithromycin, was evaluated in various rat models including carrageenan- and poly-l-arginine-induced hind-paw oedema, croton oil inflamed ear assay and polyester sponge granuloma. When administered orally to animals, roxithromycin displayed an atypical profile in the assays utilized, including: (1) marked antioedema activity similar to that of indomethacin in poly-l-arginine assay, (2) significant inhibition of λ-carrageenan hind-paw oedema and croton-oil-induced inflammation in the ear, although indomethacin was more effective, and (3) failure to reduce the development of granuloma induced by implanted polyester sponges, while indomethacin significantly reduced the chronic inflammatory reaction. Based on these results, it is concluded that roxithromycin is active in reducing the acute inflammatory reaction in rat models through mechanisms different from conventional nonsteroidal antiinflammatory agents such as indomethacin. Therefore, roxithromycin may have a favorable impact on skin inflammatory reactions accompanying microbial infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A. L. Barry, C. Thornsberry and R. N. Jones,In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin and clindamycin, Antimicrob. Agents Chemoter.31, 343–345 (1987).

    Google Scholar 

  2. R. A. Young, J. P. Gonzalez and E. M. Sorkin,Roxithromycin: A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs37, 8–41 (1989).

    PubMed  Google Scholar 

  3. T. Tomomasa, T. Kuroume, H. Arai, K. Wakabayashi and Z. Itoh,Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig. Dis. Sci.31, 157–161 (1986).

    PubMed  Google Scholar 

  4. V. Annese, J. Janssens, G. Vantrappen, J. Tack, T. C. Peeters, P. Willemse and E. Van Cutsem,Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination. Gastroenterology102, 823–828 (1992).

    PubMed  Google Scholar 

  5. T. L. Peeters, G. Matthijs, I. Depoortere, T. Cachet, J. Hoogmartens and G. Vantrappen,Erythromycin is a motilin receptor agonist. Am. J. Physiol.257, G470-G474 (1989).

    PubMed  Google Scholar 

  6. G. Plewig and E. Schopf,Anti-inflammatory effects of antimicrobial agents: An in vivo study. J. Invest. Dermatol.65, 532–537 (1975).

    PubMed  Google Scholar 

  7. J. P. Tarayre, M. Aliaga, M. Barbara, G. Villanova, R. Ballester, J. Tisne-Versailles and J. P. Couzinier,Cutaneously applied erythromycin base reduces various types of inflammatory reactions in mouse ear. Int. J. Tissue React.9, 77–85 (1987).

    PubMed  Google Scholar 

  8. T. Barlam and H. C. Neu,In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob. Agents Chemoter.25, 529–531 (1984).

    Google Scholar 

  9. M. Campa, I. Zolfino, S. Senesi, N. Bernardini, R. Danesi, M. Ducci, M. Oleggini, R. Di Stefano, F. Mosca, A. Lazzarini and M. Del Tacca,The penetration of roxithromycin into human skin. J. Antimicrob. Chemoter.26, 87–90 (1990).

    Google Scholar 

  10. M. Del Tacca, R. Danesi, N. Bernardini, M. Ducci, I. Zolfino, S. Senesi, E. Panattoni, M. Gabriele, M. Marcucci, A. Lazzarini and M. Campa,Roxithromycin penetration into gingiva and alveolar bone of odontoiatric patients. Chemotherapy36, 332–336 (1990).

    PubMed  Google Scholar 

  11. P. Agache, P. Amblard, G. Moulin, H. Barriere, L. Texier, C. Beylot and H. Bergoend,Roxithromycin in skin and soft tissue infections. J. Antimicrob. Chemother.20 (suppl. B), 153–156 (1987).

    PubMed  Google Scholar 

  12. J. Sasaki,Clinical evaluation of roxithromycin in odontogenic orofacial infections. J. Antimicrob. Chemoter.20 (suppl. B), 167–170 (1987).

    Google Scholar 

  13. H. Makino, S. Kuzuna, T. Naka, T. Saijo and Y. Maki,Antiinflammatory, analgesic, and antipyretic activities of methyl-7-butyl-4,5,6,7-tetrahydro-3-methylamino-4-6-dioxo-5-propyl-2H-pyrazolo[3,4-d]pyrimidine-2-carboxilate (AA-2379), a novel non-acidic agent. Agents and Actions25, 385–393 (1988).

    PubMed  Google Scholar 

  14. S. Kumakura, M. Mishima, S. Kobayashi, H. Shirota, S. Abe, K. Yamada and S. Tsurufuji,Inhibitory effect of indomethacin farnesil, a novel antiinflammatory prodrug, on carrageenan-induced inflammation in rats. Agents and Actions29, 286–291 (1990).

    PubMed  Google Scholar 

  15. E. Antunes, M. Mariano, G. Cirino, S. Levi and G. de Nucci,Pharmacological characterization of polycation induced rat hindpaw oedema. Br. J. Pharmacol.101, 986–990 (1990).

    PubMed  Google Scholar 

  16. L. M. Brand, K. L. Skare, M. E. Loomans, H. H. Reller, R. J. Schwen, D. A. Lade, R. L. Bohne, C. S. Maddin, D. P. Moorehead, R. Fanelli, C. Chiabrando, M. G. Castelli and H. H. Tai,Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Agents and Actions31, 329–340 (1990).

    PubMed  Google Scholar 

  17. C. J. E. Niemegeers, W. Van Bruggen, F. Awouters and P. A. J. Janssen,The effects of suprofen in rats with implanted cotton pellets. Arzeim.-Forsch. (Drug Res.)25, 1524–1526 (1975).

    Google Scholar 

  18. G. A. Higgs, K. G. Mugridge, S. Moncada and J. R. Vane,Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW7555c. Proc. Natl. Acad. Sci. USA81, 2890–2892 (1975).

    Google Scholar 

  19. A. Kitchen,Methods for the assessment of drug action on cellular accumulation. InAnti-inflammatory Compounds. InClinical Pharmacology, Vol. 9 (Ed. W. R. N. Williamson) pp. 153–191, Marcel Dekker, New York 1987.

    Google Scholar 

  20. W. T. Shier and D. J. DuBourdieu,Polycations as prostaglandin synthesis inducers. II. Structure-activity relationships. Prostaglandins31, 1145–1157 (1986).

    PubMed  Google Scholar 

  21. L. Needham, P. G. Hellewell, T. J. Williams and J. L. Gordon,Endothelial functional responses and increased vascular permeability induced by polycations. Lab. Invest.59, 538–548 (1988).

    PubMed  Google Scholar 

  22. L. J. Ignarro, M. E. Gold, G. M. Buga, R. E. Byrns, K. S. Wood, G. Chaudhuri and G. Frank,Basic polyamino acids rich in arginine, lysine or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein. Circ. Res.64, 315–329 (1989).

    PubMed  Google Scholar 

  23. C. Vigo, G. P. Lewis and P. J. Piper,Mechanism of inhibition of phospholipase A 2. Biochem. Pharmacol.29, 623–627 (1980).

    PubMed  Google Scholar 

  24. M. Simionescu, N. Simionescu, J. E. Silbert and G. E. Palade,Differential microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites. J. Cell Biol.90, 614–621 (1981).

    PubMed  Google Scholar 

  25. Y. Miyachi, A. Yoshioka, S. Imamura and Y. Niwa,Effect of antibiotics on the generation of reactive oxygen species. J. Invest. Dermatol.86, 449–453 (1986).

    PubMed  Google Scholar 

  26. K. Dalziel, P. J. Dykes and R. Marks,The effects of tetracycline and erythromycin in a model of acne-type inflammation. Br. J. Exp. Path.68, 67–70 (1987).

    Google Scholar 

  27. M. T. Labro, J. El Benna and C. Babin-Chevaye,Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. J. Antimicrob. Chemother.24, 561–572 (1989).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto di Farmacologia Medica, Università di Pisa, Via Roma 55, I-56126, Pisa, Italy

    C. Agen, C. Blandizzi, M. Costa, B. Stacchini & M. Del Tacca

  2. Scuola Superiore di Studi Universitari e di Perfezionamento S. Anna, Via G. Carducci 40, I-56123, Pisa, Italy

    R. Danesi

  3. Roussel Pharma, Viale Gran Sasso 18, I-20133, Milano, Italy

    P. Favini

Authors
  1. C. Agen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Danesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Blandizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Stacchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Favini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Del Tacca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agen, C., Danesi, R., Blandizzi, C. et al. Macrolide antibiotics as antiinflammatory agents: Roxithromycin in an unexpected role. Agents and Actions 38 (Suppl 1), 85–90 (1993). https://doi.org/10.1007/BF02027218

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02027218

Keywords

Search

Navigation